N04BD MAO B Inhibitors, dopaminergic anti-parkinson drugs
ATC group of level 4 – chemical subgroup · in plain English: medicines for Parkinson's disease
This site has the patient leaflet or the SPC of 25 medicines in this group and its subgroups.
- 23 prescription only (POM)
- 2 no longer supplied or not available
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- N Nervous system drugs 4,479 medicines
- N04 Anti-parkinson drugs 315 medicines
- N04B Dopaminergic agents 292 medicines
-
N04BD MAO B Inhibitors, dopaminergic anti-parkinson drugs 25 medicines
- N04BD01 selegiline 4 medicines
- N04BD02 rasagiline 15 medicines
- N04BD03 safinamide 6 medicines
-
N04BD MAO B Inhibitors, dopaminergic anti-parkinson drugs 25 medicines
- N04B Dopaminergic agents 292 medicines
- N04 Anti-parkinson drugs 315 medicines
Active substances in the group
- Rasagiline 15 medicines
- Safinamide 6 medicines
- Selegiline 4 medicines
Medicines in the group and its subgroups
Other groups of the same level
- N04BA Dopa and dopa derivatives 83 medicines
- N04BB Adamantane derivatives, dopaminergic 11 medicines
- N04BC Dopamine agonists 161 medicines
- N04BX Other dopaminergic agents 12 medicines
Other names of the ATC group
- Czech: N04BD Inhibitory monoaminooxidázy typu B
- French: N04BD inhibiteurs de la monoamine oxydase type b
- German: N04BD Monoaminoxidase-B-Hemmer
- Spanish: N04BD Inhibidores de la monoaminooxidasa (antiparkinsonianos)
- German: N04BD Monoaminoxidase-B-Hemmer
- Italian: N04BD Inibitori della monoaminossidasi B
- Polish: N04BD Inhibitory monoaminooksydazy typu B
- Turkish: N04BD MAO B İnhibitörleri, dopaminerjik anti-parkinson ilaçları
- Portuguese (Brazil): N04BD Inibidores da monoamino-oxidase tipo B
- Slovak: N04BD Inhibítory monoaminooxidázy typu B
- German (Switzerland): N04BD Monoaminoxidase-B-Hemmer
- French (Switzerland): N04BD Inhibiteurs de la monoamine oxydase type b
- Italian (Switzerland): N04BD Inibitori della monoaminossidasi B
- Dutch: N04BD MAO-B-remmers, dopaminerge antiparkinsonmiddelen
- English (Canada): N04BD MAO B Inhibitors, dopaminergic anti-parkinson drugs
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N04BD
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.